about
Optimizing the Detection of Circulating Markers to Aid in Early Lung Cancer DetectionBiomarkers of risk to develop lung cancer in the new screening eraEarly detection of lung cancerCirculating microRNA Biomarkers as Liquid Biopsy for Cancer Patients: Pros and Cons of Current AssaysMicroRNAs in cancer: from developmental genes in worms to their clinical application in patientsFuture microfluidic and nanofluidic modular platforms for nucleic acid liquid biopsy in precision medicine.Diagnostic and Therapeutic Potential of MicroRNAs in Lung Cancer.Do Lung Cancer Eligibility Criteria Align with Risk among Blacks and Hispanics?Plasma miR-19b and miR-183 as Potential Biomarkers of Lung Cancer.Lung Cancer Early Detection: The Role of Circulating MicroRNAsMiR-374a suppresses lung adenocarcinoma cell proliferation and invasion by targeting TGFA gene expression.Extracellular mRNA Detected by Tethered Lipoplex Nanoparticle Biochip for Lung Adenocarcinoma Detection.Early detection and early treatment of lung cancer: risks and benefits.A serum-circulating long noncoding RNA signature can discriminate between patients with clear cell renal cell carcinoma and healthy controls.Updated therapeutic outcome for patients with periampullary and pancreatic cancer related to recent translational research.Circulating and tissue biomarkers in early-stage non-small cell lung cancerColorectal Cancer Liver Metastasis: Evolving Paradigms and Future Directions.Recent advances of microRNA-based molecular diagnostics to reduce false-positive lung cancer imaging.Micromarkers 2.0: an update on the role of microRNAs in cancer diagnosis and prognosis.Genomic approaches to accelerate cancer interception.microRNA and Lung Cancer.AJRCCM: 100-Year Anniversary. The Shifting Landscape for Lung Cancer: Past, Present, and Future.The challenge of small lung nodules identified in CT screening: can biomarkers assist diagnosis?Lung cancer screening: utility of molecular applications in conjunction with low-dose computed tomography guidelines.Multimodal lung cancer screening using the ITALUNG biomarker panel and low dose computed tomography. Results of the ITALUNG biomarker study.A 2015 survey of established or potential epigenetic biomarkers for the accurate detection of human cancers.Circulating Cancer Biomarkers: The Macro-revolution of the Micro-RNAPathologists and liquid biopsies: to be or not to be?Non-Coding RNAs in Lung Cancer: Contribution of Bioinformatics Analysis to the Development of Non-Invasive Diagnostic Tools.MicroRNA-21 versus microRNA-34: Lung cancer promoting and inhibitory microRNAs analysed in silico and in vitro and their clinical impact.Integration of multiple "OMIC" biomarkers: A precision medicine strategy for lung cancer.Update in Lung Cancer 2015.Targeting MicroRNAs in Prostate Cancer Radiotherapy.Smoking and Lung Cancer: A Geo-Regional PerspectiveMolecular profile of liquid biopsies: next generation biomarkers to improve lung cancer treatment.Management of the pulmonary nodule-shifting paradigms and an opportunity for change.The clinical use of circulating microRNAs as non-invasive diagnostic biomarkers for lung cancers.Looking for sputum biomarkers in lung cancer secondary prevention: where are we now?Current and Prospective Protein Biomarkers of Lung Cancer.Circulating tumour cells as a potential screening tool for lung cancer (the AIR study): protocol of a prospective multicentre cohort study in France.
P2860
Q26745560-5D3795BD-909E-4526-ACC4-215807321C2FQ26747784-1CA47FD1-6474-48A2-9F37-A392A7AA3ED7Q26751228-9CCADCBC-8009-4AED-8FA2-329104684C84Q26777992-FF0D2D31-E4C1-4437-BFD4-0A6A238AE106Q26865275-39A052EE-FCB4-45B9-9275-F43BCC09A03BQ30357091-46FEB38A-83AA-4467-B6D6-CFA330E47EB0Q33737293-3CDE99E8-FFA8-4B22-A448-E182356DF580Q35855468-CA93AB57-53EB-4592-B417-AC0546FD2514Q36170868-001C9436-49F1-4E56-8487-EE2153D999E5Q36252671-625478F1-8F8D-4BA2-8C21-5A8D46F66542Q36927000-340C20EC-2D1A-4161-AABE-A80C1FEAC2EFQ37013152-38B07539-B8B9-4165-AF8D-23940499E205Q37329515-5919FAAE-319E-4C85-A28D-E886E5252239Q37499241-BA200108-2140-4C9E-B7B8-F1A769339913Q37538915-56D15F40-6A0D-42F1-B14F-E59B7179032CQ37629653-08089FD1-77B8-48D1-9AD8-4EFFD493B0C3Q37673704-8F193E94-AC72-46ED-BA90-2A35E07023E8Q38449526-2A8DC0E7-87F8-4E2E-B015-8AF863C62D53Q38580491-86E3E4C8-119D-44EA-ADF1-16241DD5178DQ38651767-EF8806AD-3194-46EC-A986-FAEB91737D43Q38667020-C7276F1C-FE15-4918-9E83-5C56AAECC886Q38689104-153FB311-8619-4251-9446-8C203CD465B1Q38695926-44341507-6578-460B-8DF2-6458B941F649Q38718638-E7D560E6-F7EF-4642-B1A0-476974333CD0Q38733634-48789748-EDD9-466B-AB8B-36AD8E8BFEC7Q38777365-05EEE79B-AF20-4353-94B9-B6F62D03EE11Q38807960-1D489588-31C5-4E0C-A4F9-86EDE7AADD89Q38935060-469D8957-BB2E-4948-A567-728275B88612Q39062958-15EADFE2-6B2C-494E-BBD4-F5A3FC3CDE88Q39433270-582747FF-1733-4CC5-AA78-C9E7CFA52483Q39655096-1259A73D-3018-4B8E-899F-79EFB60FF804Q41115829-05AE4083-E990-4A30-B59F-D509378E323CQ41239908-0529F1F9-09D4-4757-8D6B-F1937ABA42E2Q41619467-2485C882-3E76-449C-BC80-71FA9CF04A75Q42129522-8DACA959-7E78-4359-A39F-6FDDE6B13DB0Q42346117-FCF8A0D3-416D-4F7C-8E8E-396B09E14ACFQ45937007-DFBD8F2E-9392-4327-A6D1-993D8909EA51Q47114964-D879AD12-C6E4-4998-B65C-74B1CC2A4098Q47130839-8210452B-13A6-4B01-8E29-1B8DF041F3D1Q47184322-5472DECC-0D3A-4595-8EF6-145883CFC076
P2860
description
im März 2015 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 19 March 2015
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в березні 2015
@uk
name
miR-Test: A Blood Test for Lung Cancer Early Detection
@en
miR-Test: A Blood Test for Lung Cancer Early Detection
@nl
type
label
miR-Test: A Blood Test for Lung Cancer Early Detection
@en
miR-Test: A Blood Test for Lung Cancer Early Detection
@nl
prefLabel
miR-Test: A Blood Test for Lung Cancer Early Detection
@en
miR-Test: A Blood Test for Lung Cancer Early Detection
@nl
P2093
P2860
P50
P356
P1476
miR-Test: a blood test for lung cancer early detection
@en
P2093
Cristiano Rampinelli
Fabio Dezi
Fabrizio Bianchi
Francesca Montani
Giuseppina Bonizzi
Lorenzo Spaggiari
Massimo Bellomi
Pier Paolo Di Fiore
Raffaella Bertolotti
Rose Mary Carletti
P2860
P304
P356
10.1093/JNCI/DJV063
P407
P577
2015-03-19T00:00:00Z